Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Outstanding. This is a post that I copied from a long share holder(MIke) on another board. It pretty much sums it up
Within the next week or two, if we see an NHS released piece of news that the NHS will be aggressivley puting a remote device to patient notes in the hands of all physicians and nurses within the next xxx years, those who bash the company will be feeling very ignorant - and those that did not buy more will be feeling almost as ignorant. Accordingly, within the next week or two, if we do not see a piece of news released from the NHS and no apparrent plan to adopt the device for the future in the NHS is preceived by us investors, those who bashed the company will be looked upon like saviors of the world and those that did not buy more at these low prices will be feeling a little bit better that they did not lose more by investing. Which way will this unfold? I am still leaning towards Medify being successfull - and am going to collect another small amount of shares at these low prices (then pray that this will indeed positively move forward!). Hang in there folks, judgement day will soon come * i hope i did not offend any jahova witnesses with the use of terminology as analogy *
Stock is on the climb.
Regards to the article
JB:
Our system gives secure remote access to the existing electronic patient notes that are already held at everyone's local General practitioners surgery. We are not down loading or up loading the patient notes into a separate data base, we are just securely access them as your Doctor does very day in his surgery.
What this means is that the patient notes which are already loaded and held at the surgery which is accepted by the patient can now be accessed when the clinician, or nurse, is with the patient at their home, in the hospital or anywhere improving care and the patients clinical safety whilst being treated.
The issue with the article is that these notes on mass will be lifted form every surgery and deposited into a single repository which by definition, increased the risk of unsecured access. Thus this article actually adds more weight to the Medify proposition. Bear in mind our solution is accessed securely through the national spine through N3, whereas the Pearl offering is outside of the national spine and thus the security risks as highlighted in the article definitely apply to them.
20/23 no volume
freeze frame
You don't miss a trick, nice start.lol
With all sincerity, I agree with you. I am going to get to someone in Doncaster to verify the meeting and any details that I can on the event/meeting the other day. I have to check the archives of pr's and emails to the names of directors that stated information before. I think one person was Joanne Webster from the NHS? Again I have to dig. For right now Clancy I still have the mindset. I believe, I believe, it's silly but I believe. And Saint Nick is around the corner, so who knows what could happen. Trust but verify. I'm on a mission from GOD( another good movie).
TK
Verylong, Based on you dealings with other CEO's and companies do you think this is a credible statement in your opinion?
I can't believe that anyone can think that this is a scam.
The news will take this to the moon. At current 12/1 split 100+ a share. IMO I wouldn't make any decisions until all this news comes out. Just think about it, if MDFY can have contracts at over 1 billion per year, do the math what should the PPS be? GLTA
Herbie,
You will see the revenues in the Quarterly reports. I wouldn't worry about that.
I knew you would be right on cue! Good stuff.
I will tell you this, I use to own retail dollar stores, and I had to jump through soooooo many legal, and governmental hoops to sell different types of goods, but on much smaller scale than MDFY. At my largest I had 17 employees. My point is after almost 2 years in this venture, hours of education,lots of cash, and emails to and from JB, I get the sense that this company is about to POP. I truly believe that the contracts are lined up with millions if not billions of dollars(over the course of the contract), but there is something holding him up..... fill in the blank. IMO
GLTA
I thought that there was a sticking point, that is harder for JB than he thought. Maybe someone or some company is holding them back? any thoughts?
Can't you taste it lem? It seems to me that there is a sticking point, and JB has get through it. There is too much good information about this company to think otherwise.
Go JB GO Were just in Freeze Frame.
MDFYFORLONG
Can you copy and send the link to me that you used to get to the meeting information. I want to call them and talk to someone at the NHS. One way or another I will talk to somebody. thanks.
On a successful meeting and the annual report news, IMO they will have a NHS national product launch soon, and the announcement of EMIS going live to all their users as well. Who knows maybe Oracle would buy them out if the mubmbes were big enough. I think the forward book is on target and growing as we speak. This will be HUGE, again IMO GLTA
Rally, Rally, Rally!!!! Go JB GO
I'm with solid, I can almost taste contracts!!!Lem we need some gear up music.
IS that you trying to sell at .15?
As well from JB.
"we are meeting with EMIS and the NHS tomorrow as per quoted many times in the public domain and PCT records. There are only two reason why we would be present at a joint meeting, to either terminate, or coordinate the escalation of roll out.
Currently, I am in an extremely good mood"
I feel much better now.
That was very strange. any thoughts on how that person made money?
I emailed JB on a number of issues, he responded last week about the same time he did to Solid with the same info. I will let you know if he gets back to me from this morning.
What were they sold for?, and who made money?
What do you mean?
how can it go down that far with only 3,750 shares traded?
Is that possible? .05?
I have on my calander from 4 weeks ago that big news at the latest is this week. Have faith people, I believe. All signs point to yes.imo. Have great day, and a better tomorrow.
So, what does everyone want for Christmas?
And it starts this week ! imo.
God Bless You. Do you need a tissue? lol
It means the bottom line brother!!!!!!! I told you MCA !!!!
Patience
Is there a way to find out how well or not medify is doing in Doncaster?
Going This is how it works in Outlook
GO to inbox and right click on an email.
Go down and click properties
Then click detail tab
Then copy the ip address
Then paste it on the ip webite.
and your in.
Absolutely
Maybe they couldn't see the forest through the trees. The BIG picture...
Sorry MCA your born with it. Good luck to you
Good things to come !! Have a great day everyone !
I think we should all read this again, and remember that it hasn't even been 1 month(business days) since it was published.
Investors update September 2006 - Chairman's Statement
"At this important time for Medify Solutions, I and the board felt that it was appropriate to provide a brief update of the developments, achievements and position of the company. This update will provide the actual and up to date position of the company which is strong, very secure and delivering the planned success." - Jonathan Bryant.
Partners
AlwaysOn - Hosting and Billing Platform for Medify's mobile proposition*
BlackBerry -RIM - Corporate Sales, Marketing and Support and device product development*
CM Isitel Spa - Italy, Spain and Latin America, sales and marketing*
EMIS - Contract, sales and Marketing support, supply IT systems to 65% of the NHS*
NHS (UK) - Project support and sponsorship, largest client for Medify and the worlds second largest employer (1.5m employees)
N3 - the national spine (electronic highway for the NHS) accreditation and approval
Oracle - Technical, Sales and Marketing and product support*
Orange - Sales and Marketing and device support and supply*
Vodafone - Sales and Marketing, NHS project sponsorship and device support and supply*
* denotes current route to market and customer channels provided for Medify.
Product status as of Quarter 4 2006
100% owned Product IPR
100% in house managed services
100% own product hosting
Medify is the only company to have approved, accredited and owned product access to the NHS national spine (N3) for patient notes.
Medify branded billing platform - customer ownership.
The ability to provide a complete mobile service creating Mobile Virtual Network Operator Status (MVNO) for Medify, now a mobile Telco not just an application developer.
68% Gross profit margins
Multiple routes to market
Provision of MedifyRemote available through Microsoft platform devices and now BlackBerry devices.
Through the BlackBerry partnership and Medify's now MVNO status, extended product range including accredited e-mail and mobile service as optional extra to MedifyRemote.
Revenue status
MedifyRemote product was delivered to the first Doncaster site on the 1st September 2006. The rollout of product to other sites within the Doncaster locality will be dictated to the company by Doncaster. As this happens, (monthly), the company will provide the status of the number of units delivered from 1st September 2006.
It is accepted by all partners that MedifyRemote will be made available to the Doncaster locality first. Then it will be made available to all EMIS customers by EMIS. Then it will be marketed to all NHS customers by Medify directly and through its corporate partners. This will occur during the next 12 months and has already begun as previously stated.
It is important to note that:
The product is being delivered to the planned NHS sites starting with Doncaster. 1.4m potential NHS customers.
Doncaster Central PCT is merging with two other PCTs.
Due to the significance of the MedifyRemote product, any adverse or negative news will be first issued by the relevant governing body, the NHS through Doncaster. To date there are no such reports and neither we nor Doncaster expect there to be.
EMIS Central Sales department have requested the current Medify Solutions Limited Sales materials for MedifyRemote to be made available for their sales representatives for use with their customers. The documentation was sent to EMIS on Friday 8th September. This is part of the marketing agreement between Medify Solutions Limited and EMIS and the use of this material is at the discretion of EMIS.
It is customary during July and August that national holidays are taken in Italy. The Medify Europe Project team are due in Rome to finalise details of the next stage of the contract with CM Isitel Spa which includes roll out and delivery. Full reporting on this project will form now on be provided by the Medify Europe management team.
Revenue figures, actual, will be produced and provided publicly during quarter 4 2006.
National roll out
As stated this has already begun with the first sites receiving kit on the 1st September 2006. From this point a planned and strategic roll will be undertaken with our partners as stated above. Medify is the only company to have approval for mobile delivery of secured access to patient notes for and within the NHS. News on our competition is favourable, as made public in the press two weeks ago, and thus we have a window of opportunity to maximise and secure the company’s current and future position. Roll out has begun, will continue and will be reported continually during quarter 4 2006.
The company has begun a programme of interviews, articles and direct to market activities to ensure market awareness for MedifyRemote. This began with interviews for the BBC and will culminate with strategic meetings with NHS national leads.
Customers actively marketed during quarter 4
1.4million healthcare professionals in the UK - MedifyRemote
124 000 EMIS customers - MedifyRemote
136 000 Partner customers - Mobile package
Equivalent number of Healthcare professionals in Italy and Spain - MedifyRemote
Subsidiary Floats
The planned float of Medify's European subsidiary and the extra-ordinary share holder dividend is confirmed and stands. The process was delayed due to the holiday period and the confirmed date of float will be announced shortly as all parties are now returned from vacation, including prospective investors. All information pertinent to the float will be made public prior to the float and all stock issued under the extra ordinary shareholder dividend will be free trading from the date of issuance and floatation.
Medify Solutions Limited (US) intends to float a subsidiary in Asia before Christmas 2006, plans are current, underway and on-going to ensure delivery.
New business
As a direct result of the publicly announced partnership with BlackBerry and Medify's now MVNO status, Medify has negotiated provision of mobile services to 136 000 healthcare professionals for and on behalf of a corporate partner. This provision, via Medify’s N3 accreditation, will provide as a package and billed by Medify:
Mobile phone services (calls and data)
MedifyRemote
Mobile e-mail
Contract principles have been agreed and formal contract arrangements are being completed. This service will be offered as a branded solution, billed through the Medify MVNO service and managed in-house by the company. The service will be provided and based on the standard MedifyRemote charges.
Board news
The board received a proposal from the Executive Chairman and founder of the Group of Companies for the Board has now resolved and approved an unlimited private purchase and “buy back” of company stock by the Chairman in the open market.
That is what my point was, hence the question mark. I agree with you.
Still in a November 2006 issue from Oracle. A scam??
Partner News In the NOVEMBER 2006 issue
Price, Performance, and Access
Medify Expands with Oracle
Building on its success in the U.K., Medify Solutions, a provider of remote access to medical information, is partnering with Oracle to expand its operations in Europe. In Italy, Medify will operate through CM Isitel; Oracle will work with this group to deliver remote patient note access to Italy's national health service.
Medify has announced that the 1.4 million employees and 500,000 healthcare professionals of the U.K. National Health Service (NHS) will begin transitioning to its MedifyRemote solution on September 1, 2006. (The initial rollout site has approximately 2,500 users.) MedifyRemote allows secure remote access to a patient's record through a Pocket PC. The solution is applicable to all NHS/Healthcare software systems. Medify has an exclusive contract with Egton Medical Information Systems (EMIS), the U.K.'s leading IT supplier in primary healthcare, to provide its technology to EMIS users.